In the UK prostate cancer is the most common cancer in men and the second most common cancer overall. One in eight men will develop prostate cancer, with over 50% of prostate cancer diagnoses in people aged 70 or above. There were 52,300 cases of prostate cancer between 2016 and 2018 and incidence rates are […]
Dr Alison Starke, Dr Niall MacDougall
St Bartholomew's Hospital
Since October 2021 cancer networks have been measured against the new Faster Diagnostic Standard (FDS), which states that a patient should have a diagnosis or exclusion of cancer within 28 days from referral. Prostate cancer diagnosis, especially since the universal implementation of multi-parametric MRI (mpMRI), has always been a challenge to the fast-track diagnostic process, […]
Dr Harry Bardgett
Bradford Teaching Hospitals NHS Foundation Trust
Einstein once said: “To look to the future, we must first look back upon the past,” and it is interesting to note that the very first prostate biopsies performed in the early 20th century by Benjamin Barringer at Memorial Hospital in New York were obtained via the perineum (the skin overlying the prostate). The close […]
Dr Olly Hulson
Leeds Teaching Hospitals NHS Trust
MRI of the penis can be performed in acute patients, particularly those presenting with symptoms of an acute penile fracture or priapism. It is reasonably quick to perform and if patients are in acute pain can give good quality images without the need for direct pressure on the penile and scrotal areas, which may be […]
Dr Jane Belfield, Leo Papadopoullos, Dr Peter Rowlands
Liverpool University Hospitals NHS Foundation Trust
Focal therapy for prostate cancer has undergone a renaissance during recent years. The advent and utilisation of high quality multiparametric prostate MRI has meant that a growing number of men are able to have small but suspicious prostate lesions detected and ultimately targeted for biopsy. Undoubtedly the PROMIS and PRECISION trials have played a significant […]
Dr Alex King, Rory Heard
University Hospital Southampton
More than 47,500 men are diagnosed with prostate cancer each year in the UK. More than 30% of them will receive radiotherapy as part of their primary cancer treatment. Accurate radiotherapy depends on high quality imaging to localise the cancer and design the radiation treatment. Conventionally, prostate radiotherapy is planned using CT imaging. However, CT […]
Jonathan Wyatt, Dr Rachel A Pearson, Rachel Pearson, Dr Hazel McCallum
Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust
The widespread use of prostate-specific antigen (PSA) as a screening test has led to a decrease in cancer-related mortality but also to an increased detection of patients with low risk prostate cancer at biopsy. Risk stratification for prostate cancer is based on different parameters such as clinical stage, PSA, Gleason score at biopsy and an […]
Dr Francesco Giganti, Professor Caroline Moore
University College London, University College Hospitals NHS Foundation Trust
Prostate cancer is now the most commonly diagnosed non-cutaneous malignancy in the UK, accounting for over 40,000 new diagnoses and 11,000 deaths annually. It is estimated that more than 400,000 men are currently living with the disease. Recent years have seen massive improvements in the understanding and treatment of prostate cancer, in particular the treatment […]
Professor Joe O'Sullivan
Queen's University Belfast and The Northern Ireland Cancer Centre